FDA-Approved vs Research Compounds Understanding the distinction between FDA-approved peptides and research-only compounds is essential for evaluating safety: Category Examples Evidence Base Regulation FDA-Approved Semaglutide (Ozempic), Teriparatide (Forteo), Tesamorelin (Egrifta) Phase I-III clinical trials, post-market surveillance Prescription required, manufactured under cGMP Previously Approved Sermorelin (Geref withdrawn 2008) Clinical trial data exists, but product no longer marketed Research use only (currently) Research Only BPC-157, TB-500, Ipamorelin, KPV Preclinical data (varying depth), no completed human trials Sold for laboratory research, not human consumption For the complete list of FDA-approved peptides and their indications, see our FDA Approved Peptides List 2026 guide
By obtaining a drivers license and using public roads, every driver has legally consented in advance to chemical testing if lawfully arrested on DUI suspicion
Reconstitution: 2.0 mL per 10 mg vial (5.0 mg/mL) for manageable injection volumes
Only pharmaceutical-grade diluents, used in accordance with the relevant SmPC and under professional supervision, should ever be considered
In this process, we provide screen-readers with meaningful data using the ARIA set of attributes